New drug trials in attention deficit disorder.
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003010:Clorgyline / Q000627:therapeutic use; D003891:Desipramine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D004311:Double-Blind Method; D005277:Fenfluramine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012642:Selegiline / Q000627:therapeutic use; D014191:Tranylcypromine / Q000627:therapeutic use
D005277:Fenfluramine; D012642:Selegiline; D014191:Tranylcypromine; D003010:Clorgyline; D003891:Desipramine; D003913:Dextroamphetamine